Overview
Share price change
24h
Current
Min
3.64
Max
3.68
Income | -4.4M -9.5M |
|---|---|
Sales | 769K 9.6M |
EPS | -0.07 |
Profit margin | -99.107 |
Employees | 129 |
EBITDA | 547K -3.3M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +295.78% upside |
Market Cap | 12M |
|---|---|
Previous open | 4.46 |
Previous close | 3.64 |
CytoSorbents Corp Chart
Past performance is not a reliable indicator of future results.
Related News
6 Oct 2026, 19:45 UTC
Cytosorbents Corp shares fell sharply, continuing a decline since Monday's close and remaining below the 20-day moving average.
Read
5 Oct 2026, 19:24 UTC
Cytosorbents Corp shares fell sharply, reaching their lowest point around midday, and remain near the lower end of their one-month trading range.
Read
2 Oct 2026, 20:12 UTC
Cytosorbents Corp is trading lower in after-market hours, reversing its recent trend of higher daily closes.
Read
1 Oct 2026, 20:02 UTC
Cytosorbents Corp announced presentations on its CytoSorb® technology at EACTS and ESICM meetings in 2026, with shares trading roughly flat since Wednesday's close.
Read
30 Sept 2026, 20:07 UTC
Cytosorbents Corporation announced new data presentations for CytoSorb at the EACTS and ESICM conferences in October 2026, with shares remaining roughly flat.
Read
29 Sept 2026, 20:07 UTC
Cytosorbents Corp's shares fell sharply after a notable high earlier, remaining well below the 20-day moving average and near the lower end of the one-month range.
Read
28 Sept 2026, 20:01 UTC
Cytosorbents Corp shares fell sharply, declining over six percent from Friday's close and remaining well below the 20-day moving average.
Read
25 Sept 2026, 19:46 UTC
Cytosorbents Corp is trading higher, recovering from an early low, although it remains significantly below its 20-day moving average amid a recent downward trend.
Read
24 Sept 2026, 20:01 UTC
Cytosorbents Corp shares fell sharply, continuing a five-session downtrend amid significant volatility and broader market weakness affecting health care equipment stocks.
Read
23 Sept 2026, 19:56 UTC
Cytosorbents Corporation regained compliance with Nasdaq's minimum bid price requirement but faces ongoing compliance issues, as shares fell sharply today amid a declining trend.
Read
21 Sept 2026, 19:55 UTC
Cytosorbents Corp is modestly higher since Friday's close, despite earlier pulling back from a session high amid broader market weakness.
Read
17 Sept 2026, 19:16 UTC
Cytosorbents Corp shares are higher as initial jobless claims fell to 196k and the Philadelphia Fed Manufacturing Index exceeded forecasts with a reading of 37.8.
Read
16 Sept 2026, 19:03 UTC
Cytosorbents Corp shares fell sharply, trading significantly lower since Tuesday's close and remaining well below the 20-day moving average.
Read
15 Sept 2026, 20:01 UTC
Cytosorbents Corp shares rebounded today, closing higher after a series of lower closes, amid broader market sentiment affected by a decline in the NY Empire State Manufacturing Index.
Read
14 Sept 2026, 20:02 UTC
Cytosorbents Corp shares are lower today, continuing a decline since Friday amid broader market concerns over rising crude oil prices and supply issues.
Read
10 Sept 2026, 17:46 UTC
CytoSorbents Corp shares are declining amid ongoing concerns about regulatory approval processes, despite announcing participation in the H.C. Wainwright conference.
Read
9 Sept 2026, 22:16 UTC
Shares of Cytosorbents Corp. traded higher during after-market hours, despite retracing from earlier gains and remaining below its 20-day moving average.
Read
8 Sept 2026, 20:01 UTC
Cytosorbents Corp shares are higher following a 1-for-20 reverse stock split, showing strong momentum since Friday's close despite remaining below the 20-day moving average.
Read
4 Sept 2026, 23:20 UTC
Cytosorbents Corp shares fell sharply in after-market hours following a reverse stock split of 1 for 20, trading significantly below their 20-day moving average.
Read
3 Sept 2026, 20:02 UTC
Cytosorbents Corporation shares are lower as the company announced a one-for-twenty reverse stock split to meet Nasdaq's minimum bid price requirement of $1.00.
Read
2 Sept 2026, 23:01 UTC
Cytosorbents Corp shares are lower in after-market trading, following significant volatility and amid heightened market sentiment from escalating U.S.-Iran tensions.
Read
1 Sept 2026, 20:01 UTC
Cytosorbents Corp shares are lower today, reflecting a modest decline since Monday's close. Broader market concerns may be influencing investor sentiment.
Read
31 Aug 2026, 21:01 UTC
Cytosorbents Corp shares are lower in after-market hours, continuing a five-session decline amid broader market pressures from hawkish Fed commentary.
Read
28 Aug 2026, 21:01 UTC
Cytosorbents Corp shares are lower in after-market trading after a volatile session, having declined following an initial rise earlier today. No specific news was identified.
Read
27 Aug 2026, 19:36 UTC
Cytosorbents Corp shares are lower today, reflecting broader market declines amid inflation data and speculation over potential Federal Reserve interest rate hikes.
Read
26 Aug 2026, 19:16 UTC
Cytosorbents Corp shares are higher amid notable volatility during Wednesday's session, fluctuating significantly while remaining in the middle of their one-month trading range.
Read
25 Aug 2026, 19:02 UTC
Cytosorbents Corp's shares are lower today, reversing earlier gains amid notable volatility. The stock has declined since Monday's close.
Read
24 Aug 2026, 21:01 UTC
Cytosorbents Corp shares are lower in after-market trading amid unusual volatility, despite earlier gains that pushed the stock near its one-month trading range.
Read
21 Aug 2026, 20:01 UTC
Cytosorbents Corp shares are higher today, continuing a strong upward trend since Thursday's close amid positive market sentiment and related equity gains.
Read
20 Aug 2026, 23:01 UTC
Cytosorbents Corp shares are lower in after-market hours, continuing a decline amid broader market pressure from disappointing sales growth at Walmart Inc.
Read
Peer Comparison
Price change
CytoSorbents Corp Forecast
Price Target
By TipRanks
12 Months Forecast
Average 15 USD 295.78%
High 15 USD
Low 15 USD
Based on 1 Wall Street analysts offering 12 month price targets forCytoSorbents Corp - Dist in the last 3 months.
Rating Consensus
By TipRanks
Neutral
1 ratings
0
Buy
1
Hold
0
Sell
Based on 1 analysts giving stock ratings to CytoSorbents Corp - Dist in the past 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$